Clik here to view.
SanBio’s US-based Phase 1/2a Clinical Trial of SB623 for the Treatment of...
TOKYO The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio, Inc.), a scientific leader in regenerative medicine for neurological disorders, hereby announces that the US-based phase 1/2a clinical...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces USFDA Final Approval and Launch of...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has received final approval from the U.S. Food and Drug...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F
HYDERABAD, India Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements...
View ArticleClik here to view.
Dr. Reddy’s Laboratories defends its right to launch Buprenorphine and...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that following the launch of its generic Buprenorphine and Naloxone...
View ArticleClik here to view.
Clik here to view.
三叶草生物制药在澳大利亚开展的SCB-313恶性腹水临床试验入组首例患者
成都 三叶草生物制药，一家致力于创新及变革性生物制药研发的生物制药公司，今天宣布在澳大利亚进行的SCB-313 I期临床试验入组首例患者。该药物是一种创新重组人肿瘤坏死因子相关凋亡诱导配体（TRAIL）- 三聚体融合蛋白，用于治疗出现恶性腹水的癌症患者。...
View ArticleClik here to view.
Clover Biopharmaceuticals Doses First Patient in Australia in Phase I Study...
CHENGDU, China Clover Biopharmaceuticals, a biotechnology company focused on developing novel and transformative biologic therapies, today announced that the first patient was dosed in a Phase I...
View ArticleClik here to view.
世界上首款抗衰老健康食品提供商新兴和制药株式会社发布最新的抗衰老研究结果
东京 (美国商业资讯) — 以在全球实现生产性老龄化(productive aging)为目标的新兴和制药株式会社（Shinkowa Pharmaceutical Co., Ltd.，总部：东京都中央区，首席执行官：Megumi Tanaka）已收购博真堂制药株式会社（Hakushindo Pharmaceutical Co.,...
View ArticleClik here to view.
Shinkowa Pharmaceutical, Provider of World’s First Rejuvenative Health Food,...
TOKYO Shinkowa Pharmaceutical Co., Ltd., (Head Office: Chuo-ku, Tokyo, CEO: Megumi Tanaka) whose goal is to achieve productive aging around the world, has acquired all shares of Hakushindo...
View ArticleClik here to view.
Notification on Enabling and Scientifically Proving Rejuvenative Effect with...
TOKYO Shinkowa Pharmaceutical Co., Ltd., (Head Office: Chuo-ku, Tokyo, CEO: Megumi Tanaka), a company striving to achieve rejuvenation with health food and conducting clinical studies to...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Levetiracetam in Sodium...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Levetiracetam in Sodium Chloride Injection, 500...
View ArticleClik here to view.
Brightree宣布eReferral与athenahealth的集成
亚特兰大 (美国商业资讯) — Brightree是云端软件的领先提供商，这些软件帮助急诊后救护公司改善业绩和患者转归，该公司发布新的解决方案，允许居家医疗器械(HME)提供商采用athenahealth网络内部的athenaClinicals，接收来自于62,000多位医疗服务提供商的数码医嘱，这与长期以来医生将患者转介给专科医师的方式相同。 在eReferral...
View ArticleClik here to view.
オクタファルマ、Nuwiq®製剤の新しい有効成分含量が欧州で承認され、血友病A患者に対する投与法の柔軟性が高まると発表
スイス・ラッヘン （ビジネスワイヤ） — オクタファルマは本日、欧州医薬品庁（EMA）が、当社のヒト細胞株由来組み換え型第VIII因子（rF VIII）製剤Nuwiq®に対する市販承認の対象拡大を承認したと発表しました。従来の有効成分含量250、500、1000、2000国際単位（IU）に加え、新たに含量2500、3000、4000 IUの単回用バイアルが欧州で提供可能となります。...
View ArticleClik here to view.
ＰＨＣホールディングス株式会社：薬剤師の業務効率化を目指した保険薬局用電子薬歴システム「PharnesV-MX」を販売開始
東京 （ビジネスワイヤ） – PHCホールディングス株式会社（本社：東京都港区）の100%子会社である、PHC株式会社（以下「PHC」）は、このたび、保険薬局用電子薬歴システム「PharnesV-MX」を発売しましたので、お知らせします。...
View ArticleClik here to view.
Octapharma宣布Nuwiq®产品新增剂量规格在欧洲获准，提高了血友病A患者的给药灵活性
瑞士拉亨 (美国商业资讯) — Octapharma今天宣布，该公司人类细胞系衍生重组第VIII因子(rFVIII)产品Nuwiq®已获得欧洲药品管理局(EMA)的新增营销授权。除了现有的250、500、1000、2000国际单位(IU)剂量规格，新增2500、3000、4000 IU单次给药用瓶装剂量规格将在欧洲发售。...
View ArticleClik here to view.
火山噴火で家屋の破壊と住民の避難が続く中、ハワイ・コミュニティ財団が支援基金を創設
ホノルル （ビジネスワイヤ） — キラウエア火山の噴火が継続して地域社会全体を呑み込む中、ハワイ島の住民数千人が家を失って困っています。噴火は5月3日に始まり、数百の建物を壊して土地を大規模に呑み込んでいます。溶岩は太平洋に達し、活発な亀裂は20箇所以上にあり、ハワイ島プナ地区の住民の生活は依然として不安定です。 HCFのMicah...
View ArticleClik here to view.
Exactech Earns Research Award at International Computer-Assisted Surgery...
GAINESVILLE, Fla. Exactech, a leading developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, earned the Second Place Best Clinical Podium...
View ArticleClik here to view.
Cerveau Technologies, Inc. Signs Research Agreement with Kobe City Hospital...
BOSTON Cerveau Technologies Inc. today announced an agreement with the Kobe City Hospital Organisation in Japan to support multiple projects over the next several years. These research projects are...
View ArticleClik here to view.
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from...
CASTRES, France Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in...
View ArticleClik here to view.